Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human FGF-9 Antibody, R&D Systems™

Mouse Monoclonal Antibody
Supplier: R&D Systems MAB2731SP
This item is not returnable.
View return policy
Description
FGF-9 Monoclonal specifically detects FGF-9 in Human samples. It is validated for Western Blot.Specifications
FGF-9 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
FGF9, FGF-9, Fibroblast growth factor 9, fibroblast growth factor 9 (glia-activating factor), GAF, glia-activating factor, HBFG-9, HBGF-9, Heparin-binding growth factor 9, MGC119914, MGC119915, SYNS3 | |
Mouse | |
Protein A or G purified from ascites | |
RUO | |
2254 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Western Blot | |
36923 | |
Western Blot 1 ug/mL | |
P31371 | |
FGF9 | |
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human FGF-9 Met1-Ser208 Accession # P31371 | |
25 μg | |
Primary | |
Detects human FGF-9 in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) FGF-3, -4, -5, -7, -10, -11, -13, -16, -17, -18, -19, rhFGF acidic, rhFGF basic, recombinant mouse (rm) FGF-6, -8b, -8c, or -15 is observed. In Western blots, no cross-reactivity with rhFGF-3, -4, -5, -6, -7, -10, -13, rmFGF-8b, or rmFGF-8c is observed. | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction